Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
about
Host-Microbiome Interaction and Cancer: Potential Application in Precision MedicineThe Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for StrokeTrimethylamine N-Oxide: The Good, the Bad and the UnknownImpacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiotaThe systemic nature of CKD.Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acidSerum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationRelationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Fecal microbiota transplantation in metabolic syndrome: History, present and future.Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.Atherosclerosis in 2016: Advances in new therapeutic targets for atherosclerosis.Personalized microbiome-based approaches to metabolic syndrome management and prevention.Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.Dysbiosis and the immune system.Metaproteomic strategies and applications for gut microbial research.Gut Microbiota in Cardiovascular Health and Disease.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Non-alcoholic fatty liver and the gut microbiota.Genetic Variant in Flavin-Containing Monooxygenase 3 Alters Lipid Metabolism in Laying Hens in a Diet-Specific Manner.Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk.Metagenomic data-mining reveals contrasting microbial populations responsible for trimethylamine formation in human gut and marine ecosystems.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Novel Risk Stratification Assays for Acute Coronary Syndrome.Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.Genomics and metagenomics of trimethylamine-utilizing Archaea in the human gut microbiome.The Genetic Architecture of Coronary Artery Disease: Current Knowledge and Future Opportunities.Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.Metabolomics and Metabolic Diseases: Where Do We Stand?An overview of renal metabolomics.New Insight into the Dietary Cause of Atherosclerosis: Implications for Pharmacology.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Linking the Microbiota, Chronic Disease, and the Immune System.Parasites, microbiota and metabolic disease.Emerging roles of xenobiotic detoxification enzymes in metabolic diseases.The gut-kidney axis.
P2860
Q28069401-9B306C15-7039-4C01-B98A-73CAC41C364AQ28069455-B85D1EE2-5EE9-4537-9EC2-9E400F3BAFB2Q28079182-DAFF2956-7EAF-4784-921A-DBA80E8B2F88Q28359551-DC2A3AEC-90CB-4C39-AF3D-724C4871D173Q30234695-7764E94A-EEF8-46C1-B491-64EE18865501Q30248988-BD510970-3921-4422-B433-046D614FDD25Q30275023-AF0FEA2C-6C35-4ED1-ABAA-45B18D1CBAE9Q30839904-BF328B22-E6B1-4E44-A37D-2E8D05AB8AFCQ33560362-92C6F592-EB36-4B96-9527-688AACA83D7DQ33749467-CB3C6E4A-2C95-490F-AD20-5B7066CDAC0EQ33821397-22AB4418-B5AC-4824-8431-1C8E5684CD66Q33827624-C29C861E-F734-4A19-A5A5-69E1DF32ECA7Q34549423-2B8C7270-81FE-4863-B230-FCFD45B5E7FBQ36175953-4D6DAE43-37AB-4FC8-8BBD-55910CFECCB8Q36228851-3B321010-57A2-4DB8-B3BF-C06D69F9BEC3Q36297601-4912BC7C-311F-4CC3-9186-B8D907BB41DEQ36308093-A4FBBA23-8288-4680-8769-3B9436367C2FQ36329055-981CDE95-6FF1-4803-B417-D028A44B39DFQ36340545-C94540D7-9DB3-4813-8FDF-A9A7C6063EA0Q37076037-B22146BE-8101-4C45-92C7-99B107857A9CQ37215934-4F8AE15A-9B52-42DE-A119-CA97E12E27EBQ37428179-62BAEE44-D742-497C-969D-5D5D150E3460Q37434694-FDF73B3D-7631-4042-BCBC-C32A1141B580Q37486151-F16ECF73-25A3-4E29-9974-7AEE8DD61665Q37595816-4B4F25A9-429D-49D2-A6C8-B37728291420Q38635841-E8262056-F6FC-4AAF-AF14-8837EB7C4FD8Q38637363-DBD57C70-962E-4313-B52F-0F6DBCAFE5A6Q38666324-E0D0AAF7-1F32-4148-B0C7-689E1A778BDCQ38701617-EAF5F645-B28E-4B3F-B441-B0B0DBE90F36Q38741089-CCAA3122-4531-4325-B8B5-26D26EDC939DQ38764871-B13971D5-F509-44BE-A481-5A87755A630CQ38764998-EC99C3A5-ADD1-4481-8721-F221FA88DD0CQ38769689-4C6C26E5-CDBB-43D9-8DE8-89023FD44F8EQ38815775-CFBEA31B-55D5-4A77-B846-14E4DCAA1549Q38836985-3858290E-FFFE-41CD-A796-E86005AB445EQ38918147-79A3C7C1-52D4-4A4E-90EE-AA93AC04C7E8Q38953278-C94288F0-88E0-4C3B-9FB8-D82A2D49ED0EQ38975148-E75F7076-D09F-4B65-A0D1-D9F83E58FA05Q39006153-B9023C35-FE82-4930-B94B-0FC5D8B345FBQ39009765-88695917-675B-409E-931D-89CA94518DD5
P2860
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@ast
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@en
type
label
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@ast
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@en
prefLabel
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@ast
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@en
P2093
P2860
P50
P1433
P1476
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
@en
P2093
J Mark Brown
Jennifer A Buffa
Jill C Gregory
Joseph A DiDonato
Nilaksh Gupta
R Balfour Sartor
Roy L Silverstein
Stanley L Hazen
Thomas M McIntyre
P2860
P304
P356
10.1016/J.CELL.2016.02.011
P407
P577
2016-03-09T00:00:00Z